Pharmaceutical care on a patient with undergoing complicated permanent cardiac pacemaker implantation
QI Hong-liang
ZHOU Hui
LIU Bin
WU Jian
Abstract：[ABSTRACT]One 71-year-old male patient with repeated dizziness for 17 years, shortness of breath after exertion for 2 years and worse for 6 days was hospitalized. Ten months ago, the patient underwent percutaneous coronary intervention operation because of acute myocardial infarction. After admission, the dynamic electrocardiogram performance of patient showed the results as follows: sinus arrest up to 4.3 s, paroxysmal atrial tachycardia, ventricular heartbeat tachycardia. The patient was diagnosed as arrhythmia, slow fast syndrome. The patient was intravenously given amiodarone because of paroxysmal atrial tachycardia after permanent cardiac pacemaker implantation. Three days later, the patient developed nausea, vomiting, yellowish skin and abnormal of liver function with ALT of 2954 IU·L-1, AST of 156 IU·L-1. Amiodarone was withdrawn and protective liver therapy was given. After 15 days, the liver function returned to normal with ALT of 37 IU·L-1 and AST of 27 IU·L-1. Clinical pharmacists provided pharmaceutical cares on medication guidance for the patient after PCI, prophylactic antibiotics usage selection during pacemaker implantation, judgment and treatment of amiodarone-related ADRs. The patient discharged with improved condition after symptomatic treatment.
Keywords：Clinical pharmacistPharmaceutical careHepatic damageCardiac pacemaker
Publication Date：2014-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 362-364 )